跳转至内容
Merck
CN

N6658

营养混合物 F-12 Ham

With ʟ-glutamine and sodium bicarbonate, liquid, sterile-filtered, suitable for cell culture

别名:

Ham’s F-12

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352207
NACRES:
NA.75
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

营养混合物 F-12 Ham, With L-glutamine and sodium bicarbonate, liquid, sterile-filtered, suitable for cell culture

Quality Level

sterility

sterile-filtered

form

liquid

technique(s)

cell culture | mammalian: suitable

impurities

endotoxin, tested

components

L-glutamine: yes
HEPES: no
phenol red: yes
sodium pyruvate: 0.11 g/L
NaHCO3: yes

shipped in

ambient

storage temp.

2-8°C

General description

Ham′s营养混合物主要是为支持中国仓鼠卵细胞、HeLa细胞和小鼠L细胞的克隆生长而研制。也可用于原代大鼠肝细胞和大鼠前列腺上皮细胞的生长。Ham′s F-12是基于CHO细胞的克隆毒性分析的常用培养基。

Application

Ham F-12营养混合物已用于:
  • 培养过表达胰岛素受体的中国仓鼠卵巢细胞(CHO-IR)
  • 培养LAN-1细胞
  • 维持SUM149、SUM159、SUM190、FC-IBC02、BCX010和IBC3细胞
  • 以1:1 的比例与 Dulbecco’s改良Eagle’培养基(DMEM) 一起培养口腔鳞状细胞癌 (OSCC) 细胞系。


Still not finding the right product?

Explore all of our products under 营养混合物 F-12 Ham


存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Kazuko Yokota et al.
Annals of surgical oncology, 26(13), 4826-4834 (2019-09-25)
WiNTRLINC1 is a long non-coding RNA (lncRNA) that positively regulates the Wnt pathway via achaete-scute complex homolog 2 (ASCL2) in colorectal cancer. ASCL2 was recently reported to play a critical role in chemoresistance, however clinical relevance of the WiNTRLINC1/ASCL2 axis
Yoshinobu Takahashi et al.
Oncology letters, 14(1), 264-270 (2017-07-12)
Whether the poor prognosis of primary central nervous system lymphoma (PCNSL) compared with systemic diffuse large B cell lymphoma (DLBCL) is attributable to the immune privilege of the intracerebral location or to intrinsic differences in the biological characteristics of two
Toshimichi Tanaka et al.
Annals of surgical oncology, 26(5), 1401-1411 (2019-02-02)
Treatment-resistance genes limiting anticancer therapy have not been well clarified in colorectal cancer (CRC). We explored gene expression profiles to identify biomarkers for predicting treatment resistance to an anticancer drug in CRC. Six CRC cell lines were treated with phenylbutyrate



全球贸易项目编号

货号GTIN
N6658-6X500ML04061834117667
N6658-500ML04061834117650